Additionally, higher serum AFP levels and higher serum IL-13 levels were significantly associated with NASH-HCC at (OR = 7.641, 95% CI = 3.6–16.18, p < 0.001) and (OR = 1.616 95%, CI = 1.3–2.008, p < 0.001), respectively. This evidence concerns the gene IL13 and metabolic dysfunction-associated steatohepatitis.